TGF-β-Neutralizing Antibody 1D11 Enhances Cytarabine-Induced Apoptosis in AML Cells in the Bone Marrow Microenvironment

• Yoko Tabe,

  Affiliations Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, Department of Clinical Laboratory Medicine, Juntendo University School of Medicine, Tokyo, Japan

  ⨯
• Yue Xi Shi,

  Affiliation Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Zhihong Zeng,

  Affiliation Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Linhua Jin,

  Affiliation Department of Clinical Laboratory Medicine, Juntendo University School of Medicine, Tokyo, Japan

  ⨯
• Masato Shikami,

  Affiliation Department of Hematology, Aichi Medical University, Aichi, Japan

  ⨯
• Yasuhito Hatanaka,

  Affiliation Department of Clinical Laboratory Medicine, Juntendo University School of Medicine, Tokyo, Japan

  ⨯
• Takashi Miida,

  Affiliation Department of Clinical Laboratory Medicine, Juntendo University School of Medicine, Tokyo, Japan

  ⨯
• Frank J. Hsu,

  Affiliation Genzyme Corporation, Cambridge, Massachusetts, United States of America

  ⨯
• Michael Andreeff,

  Affiliation Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Marina Konopleva

  * E-mail: mkonople@mdanderson.org

  Affiliation Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯